Co-Diagnostics Analyst Price Targets - Benzinga

Co-Diagnostics Inc

CODXNASDAQ

Trade with Public

Trade with Public

$1.12

At close: Sep 9, 5:00 PM EST

$1.14

0.021.79%

Pre-Market: 3:00 AM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Co-Diagnostics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Co-Diagnostics (CODX).

Price Target Range — 9 Quarters

Analyst Consensus — 3 Analysts

1Buy

2Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$3Upside to Avg. PT+163.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jan 23, 2026	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—
Nov 26, 2025	Maxim Group	Jason McCarthy	Initiate	Buy	$2
Nov 24, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	—
Oct 28, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3
Oct 16, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3
Sep 19, 2025	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$10→$3
Sep 17, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$10
Aug 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$10
Apr 28, 2025	D. Boral Capital	Jason Kolbert	Initiate	Buy	$10
Mar 28, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$2→$1
Nov 11, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$2
Aug 12, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$2→$2
Jun 17, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$2
May 13, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$3→$2
Mar 15, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$3→$3
Dec 29, 2023	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$3
Nov 13, 2023	HC Wainwright & Co.	Yi Chen	PT Raise	Neutral	$2→$3

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Downgrades Co-Diagnostics to Hold

Maxim Group analyst Jason McCarthy downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Hold.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on Co-Diagnosticsto Neutral

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) from Neutral to Neutral.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Co-Diagnostics, Maintains $3 Price Target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $3 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Co-Diagnostics, Maintains $3 Price Target

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $3 price target.

Benzinga Newsdesk

Tesla To Rally More Than 31%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

PRO
D. Boral Capital Maintains Buy on Co-Diagnostics, Lowers Price Target to $3

D. Boral Capital analyst Jason Kolbert maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and lowers the price target from $10 to $3.

Benzinga Newsdesk